References
- Depablos-Velasco P, Salguero-Chaves E, Mata-Poyo J, et al. Quality of life and satisfaction with treatment in subjects with type 2 diabetes: results in Spain of the PANORAMA study. Endocrinol Nutr. 2014;61(1):18–26.
- Borgoño CA, Zinman B. Insulins: past, present, and future. Endocrinol Metab Clin North Am. 2012;41(1):1–24.
- Garcia-Perez LE, Alvarez M, Dilla T, et al. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4(2):175–194.
- Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530.
- Migdalis IN. Insulin analogs versus human insulin in type 2 diabetes. Diabetes Res Clin Pract. 2011;93(Suppl 1):S102–4.
- Bosworth HB, Granger BB, Mendys P, et al. Medication adherence: a call for action. Am Heart J. 2011;162(3):412–424.
- Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
- Rodriguez Chamorro MA, Garcia-Jimenez E, Amariles P, et al. [Review of the test used for measuring therapeutic compliance in clinical practice]. Aten Primaria. 2008;40(8):413–418.
- Rossi F, Umbacía L, Sánchez E. Inclusiones de medicamentos incorporados en el Plan Obligatorio de Salud (POS)-Acuerdo 029 de 2011. Bogotá: Fundación Instituto para la investigación del medicamento en los sistemas de salud-Ifarma.Colombia, 2012.
- Donnelly LA, Morris AD, Evans JM Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. Qjm. 2007;100(6):345–350.
- Dit L, Baban A, Dumitrascu DL Diabetes’s adherence to treatment: the predictive value of satisfaction with medical care. Procedia-Social Behav Sci. 2012;33:508–512.
- Machado-Alba JE, Machado-Duque ME, Moreno-Gutierrez PA. Time to and factors associated with insulin initiation in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2015;107(3):332–337.
- Farsaei S, Radfar M, Heydari Z, et al. Insulin adherence in patients with diabetes: risk factors for injection omission. Prim Care Diabetes. 2014;8(4):338–345.
- Albuquerque C, Correia C, Ferreira M. Adherence to the therapeutic regime in person with type 2 diabetes. Procedia Soc Behav Sci. 2015;171:350–358.
- Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65(3):314–322.
- Han E, Suh DC, Lee SM, et al. The impact of medication adherence on health outcomes for chronic metabolic diseases: a retrospective cohort study. Res Social Adm Pharm. 2014;10(6):e87–98.
- Patel I, Chang J, Shenolikar R, et al. Medication adherence in low income elderly type-2 diabetes patients: A retrospective cohort study. Int J Diabetes Mellit. 2010;2(2):122–124.
- Bertoldo P, Ascar G, Campana Y, et al. Cumplimiento terapéutico en pacientes con enfermedades crónicas. Revista Cubana De Farmacia. 2013;47(4):468–474.
- Krapek K, King K, Ss W, et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother. 2004;38(9):1357–1362.
- Tiv M, Viel JF, Mauny F, et al. Medication adherence in type 2 diabetes: the ENTRED study 2007, a french population-based study. Plos One. 2012;7(3):e32412.
- Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–1224.
- Asche C, LaFleur J, Conner C A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.
- Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res. 2005;36(3):300–306.
- Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118(Suppl 5A):27s–34s.
- Hartman I. Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence. Clin Med Res. 2008;6(2):54–67.